Ashkon Software

   







 


SIGA Stock Report - SIGA Technologies Inc.

SIGA Technologies Inc. logo SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

 



Stock Sector: Drugs: Biotechnology


 

 
Copyright © 2000-2023, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer